Shiomi, M.; Watanabe, R.; Ishihara, R.; Tanaka, S.; Nakazawa, T.; Hashimoto, M.
Comparative Insights on IL-5 Targeting with Mepolizumab and Benralizumab: Enhancing EGPA Treatment Strategies. Biomolecules 2025, 15, 544.
https://doi.org/10.3390/biom15040544
AMA Style
Shiomi M, Watanabe R, Ishihara R, Tanaka S, Nakazawa T, Hashimoto M.
Comparative Insights on IL-5 Targeting with Mepolizumab and Benralizumab: Enhancing EGPA Treatment Strategies. Biomolecules. 2025; 15(4):544.
https://doi.org/10.3390/biom15040544
Chicago/Turabian Style
Shiomi, Mayu, Ryu Watanabe, Ryuhei Ishihara, Sayaka Tanaka, Takashi Nakazawa, and Motomu Hashimoto.
2025. "Comparative Insights on IL-5 Targeting with Mepolizumab and Benralizumab: Enhancing EGPA Treatment Strategies" Biomolecules 15, no. 4: 544.
https://doi.org/10.3390/biom15040544
APA Style
Shiomi, M., Watanabe, R., Ishihara, R., Tanaka, S., Nakazawa, T., & Hashimoto, M.
(2025). Comparative Insights on IL-5 Targeting with Mepolizumab and Benralizumab: Enhancing EGPA Treatment Strategies. Biomolecules, 15(4), 544.
https://doi.org/10.3390/biom15040544